ESMO Asia 2015 Congress

Supportive and Palliative Care

18 Dec - 21 Dec 2015, Singapore

ESMO Asia 2015

The ESMO Asia Congress comprised both scientific and educational tracks prepared by an international scientific committee. There was a strong emphasis on state of the art science, including a call for abstracts, and the current standard of care across all major tumour types.

Abstracts, presentations and webcasts from the ESMO Asia 2015 Congress are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links





Format available

https://oncologypro.esmo.org/Meeting-Resour...ngress/Welcome-address-by-the-ESMO-President

Date: 18 Dec 2015
Presenter: Rolf A. Stahel
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...-Lung-cancer-From-nihilism-to-great-advances

Date: 18 Dec 2015
Presenter: Frances Shepherd
Resources: Presentation, Webcast
Topic: Thoracic malignancies

https://oncologypro.esmo.org/Meeting-Resour...ecture-Cancer-immunotherapy-by-PD-1-blockade

Disclosure

Date: 18 Dec 2015
Presenter: Tasuku Honjo
Resources: Abstract, Presentation, Webcast
Topics: Skin cancers, Pathology/Molecular Biology, Basic Scientific Principles

https://oncologypro.esmo.org/Meeting-Resour...-and-the-challenge-of-identifying-biomarkers

Date: 18 Dec 2015
Presenter: Annette Byrne
Resources: Presentation, Webcast
Topics: Translational Research, Basic Principles in the Management and Treatment (of cancer)

https://oncologypro.esmo.org/Meeting-Resour...015-Congress/Angiogenesis-in-gastric-cancers

Date: 18 Dec 2015
Presenter: Andrés Cervantes
Resources: Presentation, Webcast
Topics: Gastric Cancer, Translational Research, Basic Principles in the Management and Treatment (of cancer)

https://oncologypro.esmo.org/Meeting-Resour...ne-therapy-and-modality-of-patient-selection

Date: 18 Dec 2015
Presenter: Sung Bae Kim
Resources: Presentation, Webcast
Topics: Cytotoxic agents, Personalised/Precision medicine, Breast Cancer, Basic Principles in the Management and Treatment (of cancer), Therapy, Biological therapy

https://oncologypro.esmo.org/Meeting-Resour...O-Asia-2015-Congress/Tumour-board-discussion

Date: 18 Dec 2015
Presenter: Danny Chan
Resources: Presentation, Webcast
Topic: Central Nervous System Malignancies

https://oncologypro.esmo.org/Meeting-Resour...odal-treatment-in-advanced-pancreatic-cancer

Date: 18 Dec 2015
Presenter: Manuel Hidalgo
Resources: Presentation, Webcast
Topics: Cytotoxic agents, Pancreatic Cancer, Surgical oncology, Therapy, Biological therapy, Radiation oncology

https://oncologypro.esmo.org/Meeting-Resour...ker-analysis-of-LUX-head-and-neck-1-LUX-H-N1

Aim/BackgroundIn the Phase III LUX-H&N1 trial, afatinib, an irreversible ErbB family blocker, significantly improved progression-free survival (PFS) vs MTX (median 2.6 vs 1.7 mos; HR 0.80; p = 0.

Date: 18 Dec 2015
Presenter: Makoto Tahara
Resources: Abstract, Presentation, Webcast
Topics: Cytotoxic agents, Head and Neck Cancers, Therapy, Biological therapy

https://oncologypro.esmo.org/Meeting-Resour...cinoma-Interim-results-from-a-phase-1b-study

Aim/BackgroundNasopharyngeal carcinoma (NPC) exhibits high expression of PD-1, and expression of PD-1/PD-L1 correlated with poor outcome. Pembrolizumab is a potent, highly selective, humanized monoclonal...

Date: 18 Dec 2015
Presenter: Chiun Hsu
Resources: Abstract, Presentation, Webcast
Topics: Immunotherapy, Head and Neck Cancers, Therapy